MX2022007088A - Productos orales. - Google Patents

Productos orales.

Info

Publication number
MX2022007088A
MX2022007088A MX2022007088A MX2022007088A MX2022007088A MX 2022007088 A MX2022007088 A MX 2022007088A MX 2022007088 A MX2022007088 A MX 2022007088A MX 2022007088 A MX2022007088 A MX 2022007088A MX 2022007088 A MX2022007088 A MX 2022007088A
Authority
MX
Mexico
Prior art keywords
composition
weight
total weight
oral products
cannabimimetics
Prior art date
Application number
MX2022007088A
Other languages
English (en)
Inventor
Michael Andrew Zawadzki
Anthony Richard Gerardi
Steven Lee Alderman
Thomas H Poole
Christopher Keller
Ronald K Hutchens
Chris J Grimes
Jr Darrell Eugene Holton
Matthew Evan Lampe
Ross Jay Oden
Cosmos Nicolas Von
Kristen Spielbauer
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/707,117 external-priority patent/US11872231B2/en
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Priority claimed from PCT/IB2020/061476 external-priority patent/WO2021116856A2/en
Publication of MX2022007088A publication Critical patent/MX2022007088A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/308—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances vitamins
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds

Landscapes

  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Botany (AREA)
  • Agronomy & Crop Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Confectionery (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona una composición configurada para uso oral, incluyendo la composición un relleno en una cantidad de al menos el 20 % en peso, en base al peso total de la composición, y al menos un ingrediente activo que incluye uno o más materiales botánicos, estimulantes, aminoácidos, vitaminas, antioxidantes, cannabinoides, cannabimiméticos, terpenos, agentes farmacéuticos o una combinación de los mismos. La composición incluye además una sal y al menos un edulcorante. La composición tiene un contenido de humedad de al menos un 40% en peso, basado en el peso total de la composición.
MX2022007088A 2019-12-09 2020-12-04 Productos orales. MX2022007088A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/707,117 US11872231B2 (en) 2019-12-09 2019-12-09 Moist oral product comprising an active ingredient
US202063036248P 2020-06-08 2020-06-08
PCT/IB2020/061476 WO2021116856A2 (en) 2019-12-09 2020-12-04 Oral products

Publications (1)

Publication Number Publication Date
MX2022007088A true MX2022007088A (es) 2022-07-11

Family

ID=82116836

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022007088A MX2022007088A (es) 2019-12-09 2020-12-04 Productos orales.

Country Status (6)

Country Link
EP (1) EP4072336A2 (es)
JP (1) JP2023504750A (es)
AU (1) AU2020403234A1 (es)
BR (1) BR112022010872A2 (es)
CA (1) CA3160269A1 (es)
MX (1) MX2022007088A (es)

Also Published As

Publication number Publication date
BR112022010872A2 (pt) 2022-08-23
EP4072336A2 (en) 2022-10-19
CA3160269A1 (en) 2021-06-17
AU2020403234A1 (en) 2022-06-30
JP2023504750A (ja) 2023-02-06

Similar Documents

Publication Publication Date Title
MX2022015714A (es) Composicion oral efervescente que comprende un ingrediente activo.
MX2022006908A (es) Composiciones orales humedas.
WO2021116856A3 (en) Oral products
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
MX2020012265A (es) Goma de mascar en tabletas adecuada para ingredientes farmaceuticos activos.
WO2007030754A3 (en) Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Hosadurga et al. Evaluation of the efficacy of 2% Ocimum sanctum gel in the treatment of experimental periodontitis
MX2021005945A (es) Ureas ciclicas.
DE60330542D1 (de) Pharmazeutische Zubereitung enthaltend einen NMDA Rezeptor Agonisten für die Behandlung von Bewegungsstörungen
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
MX2022007089A (es) Producto oral y metodo de fabricacion.
ES2050378T3 (es) Sistema de suministro de aroma y su preparacion.
MX2023012535A (es) Composicion oral efervescente.
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
MX2022007088A (es) Productos orales.
MY153109A (en) A solid pharmaceutical formulation
PH12020500499A1 (en) Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
MX2024006239A (es) Composicion farmaceutica solida que contiene el compuesto indocianina.
MX2021005944A (es) Inhibidores de rip1.
AR000555A1 (es) Uso de composiciones anabolicas para la masa osea en base a cantidades efectivas no toxicas del ácido Ä3-(n,n-dimetilamino)-1-hidroxipropilidenoÜbisfosfonico o la sal monosodica u otra sal farmacéuticamente aceptable del mismo
SG10201807034XA (en) A pharmaceutical composition for improving or preventing progression of Chronic Kidney Disease
MX2022006978A (es) Composiciones orales con actividad acuosa reducida.
BR112022010986A2 (pt) Composição oral contendo lipídios
WO2009004039A3 (en) Hard gelatin capsule formulation comprising a pumpkin product
BR112022019449A2 (pt) Composição com melhor aceitação voluntária